ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 5.94
-0.17 (-2.78%)
Apr 17, 2026, 4:08 PM HKT
ImmuneOnco Biopharmaceuticals (Shanghai) Employees
ImmuneOnco Biopharmaceuticals (Shanghai) had 202 employees as of December 31, 2025. The number of employees increased by 46 or 29.49% compared to the previous year.
Employees
202
Change
46
Growth
29.49%
Revenue / Employee
850.00K HKD
Profits / Employee
-1.20M HKD
Market Cap
2.64B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 202 | 46 | 29.49% |
| Jun 30, 2025 | 195 | - | - |
| Dec 31, 2024 | 156 | 11 | 7.59% |
| Dec 31, 2023 | 145 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Frontage Holdings | 1,523 |
| AIM Vaccine | 1,466 |
| BioDlink International Company | 613 |
| Jiangsu Recbio Technology | 491 |
| Mabpharm | 389 |
| Mirxes Holding Company | 347 |
| Clover Biopharmaceuticals | 243 |
| Immunotech Biopharm | 183 |